Welcome to our dedicated news page for SomaLogic (Ticker: SLGC), a resource for investors and traders seeking the latest updates and insights on SomaLogic.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect SomaLogic's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of SomaLogic's position in the market.
Rhea-AI Summary
OncoHost to present new results at AACR Annual Meeting showcasing PROphet® platform's machine learning models for predicting therapeutic benefit and immune-related adverse events in NSCLC patients treated with immunotherapy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
SomaLogic, Inc. (Nasdaq: SLGC) announced stockholder approval for the transaction with Standard BioTools Inc. (Nasdaq: LAB), creating a diversified leader in life sciences tools. The merger is expected to close on January 5, 2024, subject to certain closing conditions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.11%
Tags
-
Rhea-AI Summary
Madryn Asset Management, LP (Madryn) demands SomaLogic, Inc. (Nasdaq: SLGC) to answer key questions related to the repeated adjournments of the Special Meeting of Shareholders pertaining to the proposed merger with Standard BioTools Inc. (Nasdaq: LAB). Madryn believes the Board of Directors have betrayed shareholders by delaying the Special Meeting five times for a covert vote-flipping campaign. Madryn has sent a litigation hold to the SomaLogic Board and urges shareholders interested in changing their vote to contact Madryn or the firm’s proxy solicitor.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.11%
Tags
Rhea-AI Summary
SomaLogic, Inc. (SOMA) faces challenges as fellow shareholders express concerns over the deal consideration and the company's cash assets, leading to last-minute adjournments of a special meeting.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.39%
Tags
-
Rhea-AI Summary
SomaLogic, Inc. (Nasdaq: SLGC) is urged by leading proxy advisory firms ISS and Glass Lewis to vote 'FOR' the proposed merger with Standard BioTools. The merger is expected to accelerate profitability and value creation, bringing in over $180 million of pro-forma combined revenue, over $500 million of cash, and only $68 million of debt, with $80 million in anticipated cost synergies achieved by 2026.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.16%
Tags
-
Rhea-AI Summary
Boston Millennia Partners (Nasdaq: BMP) opposes SomaLogic's (Nasdaq: SLGC) merger with Standard BioTools Inc.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
Madryn Asset Management, LP (Madryn) urges shareholders to vote 'AGAINST' the proposed merger between SomaLogic, Inc. (SLGC) and Standard BioTools Inc. (LAB). Four significant shareholders, including the company founder, have openly stated their opposition to the merger, highlighting concerns about undervaluation and a flawed process. The recommendation from proxy advisory service ISS only offered 'cautionary support' for the merger, leaving room for shareholders to vote 'AGAINST' the transaction.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
SomaLogic, Inc. (Nasdaq: SLGC) continues to recommend stockholders vote 'FOR' the pending merger with Standard BioTools, emphasizing the benefits of the transaction for all stockholders and the company's future potential.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.89%
Tags
-
Rhea-AI Summary
SomaLogic, Inc. (Nasdaq: SLGC) founders Dr. Larry Gold and Dr. Jason Cleveland express opposition to the proposed merger with Standard BioTools, Inc. (Nasdaq: LAB) in a letter to stockholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.74%
Tags
Rhea-AI Summary
SomaLogic, Inc. (Nasdaq: SLGC) responds to Madryn Asset Management's misleading press release regarding the pending merger with Standard BioTools (Nasdaq: LAB).
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.54%
Tags
SomaLogic, Inc.
Nasdaq:SLGC
SLGC Rankings
SLGC Stock Data
396.23M
153.26M
2.16%
61.71%
3.79%
Testing Laboratories
Professional, Scientific, and Technical Services
US
Boulder
About SLGC
revolutionizing proteomics to transform healthcare somalogic was founded in 2000 with the goal of improving the well-being and quality of life of every individual by transforming how diseases were detected and diagnosed. building on the previous decade of aptamer research, somalogic scientists have developed a new proteomics technology that overcomes the significant challenges of current technologies, and which has multiple applications across the biological and medical sciences. our mission is to leverage our proprietary technology to discover, develop and commercialize revolutionary new life science research tools and breakthrough clinical diagnostic products that will transform healthcare. if you would like to learn more about somalogic, contact us at information@somalogic.com or 303-625-9000